Rebecca D. Dodd

1.4k total citations
40 papers, 897 citations indexed

About

Rebecca D. Dodd is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rebecca D. Dodd has authored 40 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Rebecca D. Dodd's work include Sarcoma Diagnosis and Treatment (19 papers), CAR-T cell therapy research (9 papers) and Neurofibromatosis and Schwannoma Cases (9 papers). Rebecca D. Dodd is often cited by papers focused on Sarcoma Diagnosis and Treatment (19 papers), CAR-T cell therapy research (9 papers) and Neurofibromatosis and Schwannoma Cases (9 papers). Rebecca D. Dodd collaborates with scholars based in United States, South Korea and Russia. Rebecca D. Dodd's co-authors include David G. Kirsch, Christopher V. Nicchitta, Jeffrey K. Mito, Samuel B. Stephens, Yan Ma, William C. Eward, Mohit Sachdeva, Diana M. Cardona, Rachel S. Lerner and Brook Pyhtila and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Rebecca D. Dodd

38 papers receiving 889 citations

Peers

Countries citing papers authored by Rebecca D. Dodd

Since Specialization

Citations

This map shows the geographic impact of Rebecca D. Dodd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca D. Dodd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca D. Dodd more than expected).

Fields of papers citing papers by Rebecca D. Dodd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca D. Dodd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca D. Dodd. The network helps show where Rebecca D. Dodd may publish in the future.

Co-authorship network of co-authors of Rebecca D. Dodd

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca D. Dodd. A scholar is included among the top collaborators of Rebecca D. Dodd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca D. Dodd. Rebecca D. Dodd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma Cells 2025 ·Cancer Research Communications ·Stacia L. Koppenhafer, (unknown), Mary V. Thomas, (unknown), (unknown), (unknown), Dawn E. Quelle, Rebecca D. Dodd, David J. Gordon	0
2	Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs 2025 ·Science Advances ·(unknown), (unknown), Nicholas Borcherding, (unknown), Adam J. Rauckhorst, Wade R. Gutierrez, Shane R. Solst, Collin D. Heer, (unknown), (unknown), David G. Kirsch, Vickie Knepper-Adrian, (unknown), (unknown), Douglas R. Spitz, Eric B. Taylor, Rebecca D. Dodd	0
3	NF1^+/ex42del miniswine model the cellular disruptions and behavioral presentations of NF1‐associated cognitive and motor impairment 2024 ·Clinical and Translational Science ·Vicki J. Swier, Katherine A. White, (unknown), Tyler B. Johnson, (unknown), (unknown), David K. Meyerholz, Rebecca D. Dodd, Dawn E. Quelle, Rajesh Khanna, Christopher S. Rogers, Jill M. Weimer	3
4	Discrepancies in indel software resolution with somatic CRISPR/Cas9 tumorigenesis models 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), Wade R. Gutierrez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vickie Knepper-Adrian, Rebecca D. Dodd	2
5	Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo 2022 ·Neuro-Oncology Advances ·(unknown), (unknown), (unknown), (unknown), Mariah Leidinger, (unknown), (unknown), Stacia L. Koppenhafer, David J. Gordon, Patrick Breheny, David K. Meyerholz, Munir R. Tanas, Rebecca D. Dodd, Dawn E. Quelle	5
6	Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance 2022 ·Cancer Drug Resistance ·(unknown), (unknown), Rebecca D. Dodd, Mohammed Milhem, Varun Monga	2
7	Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism 2022 ·JCI Insight ·Wade R. Gutierrez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vickie Knepper-Adrian, (unknown), Dawn E. Quelle, David J. Gordon, Varun Monga, Rebecca D. Dodd	7
8	PRC2 loss drives MPNST metastasis and matrix remodeling 2022 ·JCI Insight ·(unknown), (unknown), (unknown), Wade R. Gutierrez, Andrew P. Voigt, (unknown), (unknown), (unknown), Vickie Knepper-Adrian, Benjamin W. Darbro, Munir R. Tanas, Christopher S. Stipp, Rebecca D. Dodd	11
9	Utility of CD138/syndecan-1 immunohistochemistry for localization of plasmacytes is tissue-dependent in B6 mice 2022 ·BMC Research Notes ·David K. Meyerholz, Mariah Leidinger, (unknown), Thomas R. Businga, (unknown), (unknown), (unknown), (unknown), Rebecca D. Dodd, Dawn E. Quelle	3
10	Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models 2021 ·Scientific Reports ·Wade R. Gutierrez, (unknown), (unknown), (unknown), Vickie Knepper-Adrian, (unknown), (unknown), Rebecca D. Dodd	8
11	RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors 2020 ·Clinical Cancer Research ·(unknown), (unknown), Casey Pulliam, (unknown), (unknown), (unknown), (unknown), Vickie Knepper-Adrian, Rajesh Khanna, Jessica C. Sieren, Mariah Leidinger, David K. Meyerholz, K. D. Zamba, Jill M. Weimer, Rebecca D. Dodd, Benjamin W. Darbro, Munir R. Tanas, Dawn E. Quelle	40
12	Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten -deleted Mouse Models of Sarcoma 2020 ·Clinical Cancer Research ·Rebecca D. Dodd, (unknown), Wesley Huang, (unknown), Wade R. Gutierrez, (unknown), Kathleen A. Ashcraft, (unknown), Parisa Yousefpour, Soumen Saha, Vickie Knepper-Adrian, (unknown), Mark Chen, Yan Ma, Eric M. Mastria, Diana M. Cardona, William C. Eward, Ashutosh Chilkoti, David G. Kirsch	7
13	Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging 2020 ·PLoS ONE ·(unknown), Devon L. Moose, (unknown), Wade R. Gutierrez, (unknown), Robert Svensson, Patrick Breheny, James A. Brown, Rebecca D. Dodd, Michael B. Cohen, Michael D. Henry	5
14	Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors 2018 ·Cancer Research ·Jacqueline D. Peacock, (unknown), Elizabeth A. Tovar, Curt J. Essenburg, Megan J. Bowman, Zachary Madaj, Julie Koeman, Elissa A. Boguslawski, Jamie Grit, Rebecca D. Dodd, (unknown), Diana M. Cardona, Mark Chen, David G. Kirsch, Flavio Maina, Rosanna Dono, Mary E. Winn, Carrie R. Graveel, Matthew R. Steensma	30
15	NF1+/− Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response 2017 ·Cancer Research ·Rebecca D. Dodd, Chang‐Lung Lee, (unknown), Wesley Huang, William C. Eward, Lixia Luo, Yan Ma, Davis R. Ingram, Keila E. Torres, Diana M. Cardona, Alexander J. Lazar, David G. Kirsch	21
16	MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes 2014 ·Journal of Clinical Investigation ·Mohit Sachdeva, Jeffrey K. Mito, Chang‐Lung Lee, Minsi Zhang, Zhizhong Li, Rebecca D. Dodd, (unknown), Lixia Luo, Yan Ma, David Van Mater, Rebecca A. Gladdy, Dina Lev, Diana M. Cardona, David G. Kirsch	84
17	NF1 Deletion Generates Multiple Subtypes of Soft-Tissue Sarcoma That Respond to MEK Inhibition 2013 ·Molecular Cancer Therapeutics ·Rebecca D. Dodd, Jeffrey K. Mito, William C. Eward, Rhea Chitalia, Mohit Sachdeva, Yan Ma, Jordi Barretina, Leslie G. Dodd, David G. Kirsch	62
18	Induction of the Unfolded Protein Response Drives Enhanced Metabolism and Chemoresistance in Glioma Cells 2013 ·PLoS ONE ·(unknown), Rebecca D. Dodd, Andrea L. Merz, Anjelika Dechkovskaia, Matthew P. Herring, (unknown), (unknown), (unknown), Helen J. Madsen, (unknown), (unknown), Jason D. White, Darell D. Bigner, Christopher V. Nicchitta, Natalie J. Serkova, Michael W. Graner	55
19	Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma 2009 ·PLoS ONE ·Jeffrey K. Mito, Richard F. Riedel, Leslie G. Dodd, Guy Lahat, Alexander J. Lazar, Rebecca D. Dodd, Lars Stangenberg, William C. Eward, Francis J. Hornicek, Sam S. Yoon, Brian E. Brigman, Tyler Jacks, Dina Lev, Sayan Mukherjee, David G. Kirsch	59
20	Stable Ribosome Binding to the Endoplasmic Reticulum Enables Compartment-specific Regulation of mRNA Translation 2005 ·Molecular Biology of the Cell ·Samuel B. Stephens, Rebecca D. Dodd, Joseph W. Brewer, Patrick J. Lager, Jack D. Keene, Christopher V. Nicchitta	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact